In the single-day compre on-line celecoxib venda cohorts, mild dizziness was reported by two of the subjects receiving 900 mg dose of ARRY-797 and moderate dizziness by pigus celecoxib sestadienis pristatymo one of the subjects receiving 800 mg followed by 400 mg ARRY-797.
In the single-day cohorts, mild dizziness was reported by two of the subjects receiving 900 mg dose of ARRY-797 and moderate dizziness by one of the subjects receiving 800 mg followed by 400 mg ARRY-797. ARRY-797 achieved its primary and secondary endpoints for analgesic efficacy and was well-tolerated celecoxib overnatter in both trials.